Evidence map›Paper›PMID 40736767›Full record

ArticleEnvironmental science & technology2025

Advanced Proteomics Approaches Hold Potential for the Risk Assessment of Metabolism-Disrupting Chemicals as Omics-Based NAM: A Case Study Using the Phthalate Substitute DINCH.

Alix Sarah Aldehoff, Isabel Karkossa, Helen Broghammer, Sontje Krupka, Juliane Weiner, Cornelius Goerdeler, Rima Nuwayhid, Stefan Langer, Martin Wabitsch, Ulrike Rolle-Kampczyk and 5 more

Abstract read
In one paragraph

Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alix Sarah AldehoffDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.ORCID 0000-0001-7994-5725
Isabel KarkossaDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.
Helen BroghammerHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
Sontje KrupkaHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
Juliane WeinerHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
Cornelius GoerdelerDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.
Rima NuwayhidDepartment of Orthopaedic, Trauma and Plastic Surgery, Division of Plastic, Aesthetic and Special Hand Surgery, University Hospital Leipzig, Leipzig 04103, Germany.
Stefan LangerDepartment of Orthopaedic, Trauma and Plastic Surgery, Division of Plastic, Aesthetic and Special Hand Surgery, University Hospital Leipzig, Leipzig 04103, Germany.
Martin WabitschDivision of Paediatric Endocrinology and Diabetes, University Hospital for Children and Adolescents Ulm, Ulm 89075, Germany.
Ulrike Rolle-KampczykDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.
Nora KlötingHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
John T HeikerHelmholtz Institute for Metabolic, Obesity and Vascular Research HI-MAG, Helmholtz-Centre Munich at the University of Leipzig and University Hospital, Leipzig 04103, Germany.
Martin von BergenDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.ORCID 0000-0003-2732-2977
Kristin SchubertDepartment of Molecular Toxicology, Helmholtz-Centre for Environmental Research GmbH (UFZ), Leipzig 04318, Germany.ORCID 0000-0003-4365-084X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of metabolic disruption through exposure to chemicals has expanded our understanding of how environmental pollution can contribute to metabolic dysregulation and, ultimately, diseases like obesity. New strategies for assessing the risks posed by chemicals are needed, and omics technologies, including proteomics, have proven to be powerful tools for investigating the molecular mechanisms of these metabolism-disrupting chemicals (MDCs). A potential MDC is the plasticizer DINCH─an alternative to legacy phthalates like DEHP, whose primary metabolite MINCH has been linked to the induction of adipogenesis and lipid accumulation. Here, global proteomics was complemented with insights into protein thermal stability and the profiles of post-translational modification (PTM) acetylation and phosphorylation to provide a profound understanding of chemical-induced metabolic disruption in adipocytes. We demonstrate the utility of advanced proteomics approaches in assessing the effects of potential MDCs by using the human SGBS adipocyte cell line. Adipose tissue PTM data from dietary DINCH-exposed mice were assessed as an

Indexed as

ProteomicsAdipocytesAnimalsHumansMicePhthalic AcidsRisk AssessmentPhthalic Acidsacetylationadipocytesadipose tissueDINCHmetabolic disruptionMINCHphosphorylationthermal proteome profiling

Identifiers

PMID40736767
PMCPMC12355959

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.